Plastomics, Inc.

Plastomics, Inc. is an innovative agricultural technology company focused on trait delivery through chloroplast transformation, enhancing crop resilience and productivity to meet global food demands. Founded in 2017 and headquartered in St. Louis, US, Plastomics, Inc.

specializes in agricultural biotechnology. The company has successfully executed six deals, with its most recent deal taking place on November 16, 2021. In this round, Plastomics raised USD 7. 1 mn in Series A funding led by Lewis & Clark Ventures, with participation from various investors, including BioGenerator and Revolution Ventures.

The CEO is Martha Schlicher, supported by senior leaders Sharon Berberich and Tania Seger, while Jeffrey Staub is identified as the founder. Plastomics specializes in a unique trait delivery technology that focuses on the chloroplasts of plant cells, allowing for enhanced expression of beneficial traits in crops. This innovative approach enables the development of seeds that are more resilient to pests, diseases, and weeds, while also yielding higher productivity. The company's core offerings aim to address significant agricultural challenges, such as the need for higher food production in response to a growing global population.

Plastomics’ technology serves agricultural seed companies, providing them with a platform that simplifies product development cycles through efficient trait stacking and reduced regulatory concerns associated with trait outcrossing. Their solutions are particularly applicable in markets like sorghum, sunflower, and rice, where high-yielding, nutritionally enhanced, and environmentally sustainable crops are in demand. Plastomics generates revenue primarily through B2B transactions with agricultural seed companies that utilize their trait delivery platform. The firm collaborates with clients to develop customized seed solutions that integrate chloroplast traits, streamlining the process from research and development to market introduction.

This partnership-based approach facilitates predictable revenue streams as seed companies rely on Plastomics for innovative traits that meet contemporary agricultural demands. The business transactions typically involve licensing agreements for the use of Plastomics’ proprietary technology, structured as one-time fees or ongoing royalties based on sales of the resulting high-yield seed products. The offerings include patent-protected technologies that enhance crop yields and nutrient profiles, critical for meeting the challenges of modern agriculture. Following the Series A funding round in November 2021, Plastomics Inc.

plans to utilize the USD 7. 1 mn raised to advance its chloroplast transformation technology, specifically focusing on demonstrating the benefits of soybean trait transformation from the laboratory to the field. The company aims to complete proof of concept for chloroplast transformation traits in corn, thereby expanding its product line. Furthermore, Plastomics is looking to broaden its market presence by targeting additional crop sectors and geographic regions, although specific markets and timelines for this expansion have not yet been disclosed.

In October 2025, Plastomics, Inc. raised USD 5. 8 million in series B funding from new investor Skull Diamond and Heart Capital, with participation from returning investors Fulcrum Global Capital, Lewis & Clark Ventures, Missouri Technology Corporation, and BioGenerator. Other unspecified investors also participated in the round.

The company will use the October 2025 funding to support its initiatives in improving crop science research.